Funding Shortfalls Pressure Small and Rural Hospitals to Delay Essential Data Security Investments; Survey of 187 Small ...

Annual General Meeting GUILDFORD, SURREY / ACCESS Newswire / June 30, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of ...

Compass Pathways has announced that its investigational psilocybin therapy, COMP360, met the primary endpoint in its Phase 3 ...

WASHINGTON, DC / ACCESS Newswire / June 30, 2025 / The not-for-profit Aimed Alliance released a comprehensive new report analyzing how state policies govern step therapy, internal and external appeal ...

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCPFirst-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy ...

PRO isn’t just digitized data collection. It’s real-time, structured, regulatory-grade intelligence, designed to enhance compliance, cut down queries, and keep patients engaged.Despite operating in a ...

A New Perspective on Addiction RecoveryIn the journey to overcome addiction, one size certainly does not fit all. Every individual faces different challenges, circumstances, and needs. While some ...

As recently announced, initial proof-of-concept results from this ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in the first participating ...

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy  Two phase 3 studies are currently underway testing riliprubart in people with CIDP as a ...

LUND, SWEDEN / ACCESS Newswire / June 30, 2025 / During June 2025, the number of shares and votes in Alligator Bioscience AB (STO:ATORX) ("Alligator Bioscience")has increased as a result of the ...

CD Genomics has launched its innovative EM-seq Service, a major advancement in sequencing technology that enhances the accuracy and efficiency of genetic analysis. This new service highlights CD ...

LOS ANGELES, CALIFORNIA / ACCESS Newswire / June 30, 2025 / Renovaro Inc.'s (NASDAQ:RENB) wholly owned subsidiary BioSymetrics has unveiled a proprietary AI-based zebrafish screening platform designed ...